Suppr超能文献

NLRP3基因缺陷减轻慢性肾脏病小鼠单侧输尿管梗阻模型中的肾纤维化并改善线粒体功能障碍

NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease.

作者信息

Guo Honglei, Bi Xiao, Zhou Ping, Zhu Shijian, Ding Wei

机构信息

Division of Nephrology, The Fifth People's Hospital of Shanghai, Fudan University, 128 Ruili Road, Shanghai 200240, China.

Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, 639 Zhizaoju Road, Shanghai 200011, China.

出版信息

Mediators Inflamm. 2017;2017:8316560. doi: 10.1155/2017/8316560. Epub 2017 Feb 28.

Abstract

The nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) inflammasome has been implicated in the pathogenesis of chronic kidney disease (CKD); however, its exact role in glomerular injury and tubulointerstitial fibrosis is still undefined. The present study was performed to identify the function of NLRP3 in modulating renal injury and fibrosis and the potential involvement of mitochondrial dysfunction in the murine unilateral ureteral obstruction (UUO) model of CKD. Employing wild-type (WT) and NLRP3 mice with or without UUO, we evaluated renal structure, tissue injury, and mitochondrial ultrastructure, as well as expression of some vital molecules involved in the progression of fibrosis, apoptosis, inflammation, and mitochondrial dysfunction. The severe glomerular injury and tubulointerstitial fibrosis induced in WT mice by UUO was markedly attenuated in NLRP3 mice as evidenced by blockade of extracellular matrix deposition, decreased cell apoptosis, and phenotypic alterations. Moreover, NLRP3 deletion reversed UUO-induced impairment of mitochondrial morphology and function. NLRP3 deletion ameliorates mitochondrial dysfunction and alleviates renal fibrosis in a murine UUO model of CKD.

摘要

含PYD结构域的核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎性小体与慢性肾脏病(CKD)的发病机制有关;然而,其在肾小球损伤和肾小管间质纤维化中的确切作用仍不明确。本研究旨在确定NLRP3在调节肾损伤和纤维化中的作用,以及线粒体功能障碍在CKD小鼠单侧输尿管梗阻(UUO)模型中的潜在影响。利用野生型(WT)和NLRP3基因敲除小鼠构建UUO模型,我们评估了肾脏结构、组织损伤和线粒体超微结构,以及一些参与纤维化、凋亡、炎症和线粒体功能障碍进展的关键分子的表达。与野生型小鼠相比,NLRP3基因敲除小鼠由UUO诱导的严重肾小球损伤和肾小管间质纤维化明显减轻,表现为细胞外基质沉积减少、细胞凋亡减少和表型改变。此外,NLRP3基因敲除可逆转UUO诱导的线粒体形态和功能损伤。在CKD小鼠UUO模型中,NLRP3基因敲除可改善线粒体功能障碍并减轻肾纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a376/5350413/89f5454bc1e7/MI2017-8316560.001.jpg

相似文献

4
Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury.
Front Immunol. 2018 Nov 12;9:2563. doi: 10.3389/fimmu.2018.02563. eCollection 2018.
5
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy.
Am J Physiol Renal Physiol. 2016 May 15;310(10):F1081-8. doi: 10.1152/ajprenal.00534.2015. Epub 2016 Feb 17.
6
9
IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis.
J Am Soc Nephrol. 2017 Jul;28(7):2022-2037. doi: 10.1681/ASN.2016080840. Epub 2017 Feb 8.
10
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
Diabetes Metab J. 2019 Dec;43(6):830-839. doi: 10.4093/dmj.2018.0181. Epub 2019 Mar 5.

引用本文的文献

1
Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines.
Ren Fail. 2025 Dec;47(1):2538798. doi: 10.1080/0886022X.2025.2538798. Epub 2025 Aug 21.
3
The pyroptosis and fibrotic diseases: a bibliometric analysis from 2010 to 2024.
Syst Rev. 2024 Nov 13;13(1):279. doi: 10.1186/s13643-024-02703-0.
4
Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease.
Kidney Dis (Basel). 2024 May 30;10(5):369-383. doi: 10.1159/000539496. eCollection 2024 Oct.
5
NLRP3 inflammasome inhibition decreases -induced granulomatous inflammation and fibrosis in BALB/c mice.
Infect Immun. 2024 Oct 15;92(10):e0005524. doi: 10.1128/iai.00055-24. Epub 2024 Aug 19.
8
Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.
Cell Death Discov. 2024 May 13;10(1):229. doi: 10.1038/s41420-024-01996-3.
9
Integrated analysis reveals crosstalk between pyroptosis and immune regulation in renal fibrosis.
Front Immunol. 2024 Jan 26;15:1247382. doi: 10.3389/fimmu.2024.1247382. eCollection 2024.
10
The Molecular Mechanism of Renal Tubulointerstitial Inflammation Promoting Diabetic Nephropathy.
Int J Nephrol Renovasc Dis. 2023 Dec 5;16:241-252. doi: 10.2147/IJNRD.S436791. eCollection 2023.

本文引用的文献

4
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy.
Am J Physiol Renal Physiol. 2016 May 15;310(10):F1081-8. doi: 10.1152/ajprenal.00534.2015. Epub 2016 Feb 17.
5
Involvement of Endoplasmic Reticulum Stress in Uremic Cardiomyopathy: Protective Effects of Tauroursodeoxycholic Acid.
Cell Physiol Biochem. 2016;38(1):141-52. doi: 10.1159/000438616. Epub 2016 Jan 15.
7
Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
Cell Physiol Biochem. 2015;36(6):2170-82. doi: 10.1159/000430183. Epub 2015 Jul 21.
8
Mechanisms linking mtDNA damage and aging.
Free Radic Biol Med. 2015 Aug;85:250-8. doi: 10.1016/j.freeradbiomed.2015.05.005. Epub 2015 May 13.
9
NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.
PLoS One. 2015 Mar 23;10(3):e0122272. doi: 10.1371/journal.pone.0122272. eCollection 2015.
10
Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury.
Am J Physiol Renal Physiol. 2015 Apr 15;308(8):F857-66. doi: 10.1152/ajprenal.00203.2014. Epub 2015 Feb 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验